A Study to Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and Females

Clinical trial NCT01199523 · COMPLETED

Trial details

NCT number: NCT01199523
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2010-05-01
Primary completion: 2010-11-01
Enrollment: 352

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.